Quidel Cp (QDEL) 21.77 $QDEL GNC Holdings Hit by Dismal

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 7:01 AM

Quidel Cp (QDEL) 21.77 $QDEL

GNC Holdings Hit by Dismal Q2 Results, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
GWPH: 81.75 (-0.02), GNC: 21.03 (+1.22), QDEL: 21.77 (+0.03), LNTH: 9.52 (-0.07)

Medtronic Posts Positive Long-term Data for Micra Pacemaker
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:00AM CDT
Medtronic's (MDT) Micra TPS also successfully reduced the risk of patient hospitalization by 47% and risk of system revisions by 82%
MDT: 87.03 (+0.18), GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), LNTH: 9.52 (-0.07)

Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.14 (+0.15), VAR: 96.13 (-0.26), QDEL: 21.77 (+0.03), IDXX: 112.68 (-0.38)

Boston Scientific's Innovation & Emerging Market Raise Hope
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:08AM CDT
On Aug 31, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).
BSX: 23.82 (-0.39), GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), LNTH: 9.52 (-0.07)

NuVasive: Strong Q2 Results, Overseas Holds Solid Prospect
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:13AM CDT
NuVasive (NUVA) posted strong results in the second quarter of 2016, with both earnings and revenues squarely beating the Zacks Consensus Estimate
GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), LNTH: 9.52 (-0.07), NUVA: 65.47 (unch)

BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.14 (+0.15), BEAT: 18.47 (-0.51), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Luminex Poised on Pipeline Strength, System Sales Upbeat
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:19AM CDT
Austin-based Luminex (LMNX) is well poised on pipeline strength and solid system sales.
MASI: 59.14 (+0.15), QDEL: 21.77 (+0.03), LMNX: 21.07 (+0.04), NUVA: 65.47 (unch)

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 81.75 (-0.02), PAHC: 24.27 (+0.38), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Uptrend Call Working As Quidel Stock Rises 20.9% (QDEL)
Comtex SmarTrend(R) - Tue Aug 30, 1:27AM CDT
SmarTrend identified an Uptrend for Quidel (NASDAQ:QDEL) on June 13th, 2016 at $17.97. In approximately 3 months, Quidel has returned 20.92% as of today's recent price of $21.73.
QDEL: 21.77 (+0.03)

Medtronic on Track with Covidien Synergy, Buys HeartWare
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:02AM CDT
On Aug 26, 2016, we issued an updated research report on Medtronic plc (MDT).
MDT: 87.03 (+0.18), GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Hill-Rom (HRC) Hits New 52-Week High on Solid Q3 Results
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:08AM CDT
Shares of Hill-Rom (HRC) rallied to a new 52-week high of $59.45 on Aug 26.
GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch), HRC: 59.31 (-0.21)

Can Veeva Systems (VEEV) Pull an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:49AM CDT
Veeva Systems Inc. (VEEV) is set to report second-quarter fiscal 2017 results on Aug 30.
VEEV: 40.92 (+3.28), LCI: 33.86 (+0.57), QDEL: 21.77 (+0.03), IDXX: 112.68 (-0.38)

Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:29PM CDT
Medtronic plc (MDT)'s reported financial results for first-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate.
MDT: 87.03 (+0.18), GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Quidel to Present at 2016 Wells Fargo Healthcare Conference
Marketwire Canada - Wed Aug 24, 3:00PM CDT
SAN DIEGO, CA --(Marketwired - August 24, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 2016 Wells Fargo Healthcare Conference to be held at The Westin Boston Waterfront hotel in Boston, MA on Wednesday, September 7, 2016.
QDEL: 21.77 (+0.03), WFC: 50.80 (+0.18)

Medtronic's HeartWare Takeover Complete for $1.1 Billion
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:54AM CDT
With HeartWare in its kitty, Medtronic (MDT) will now gracefully lead the global VAD market for heart failure patients.
MDT: 87.03 (+0.18), GWPH: 81.75 (-0.02), QDEL: 21.77 (+0.03), HTWR: 58.20 (+0.22), NUVA: 65.47 (unch)

Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 81.75 (-0.02), PAHC: 24.27 (+0.38), BAX: 46.73 (-0.16), QDEL: 21.77 (+0.03)

Illumina Rallies on Rumors of Takeover by Thermo Fisher
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:42AM CDT
Reportedly, Thermo Fisher (TMO) has made an all-stock offer of $30 billion to acquire Illumina (ILMN), which currently has a market cap of over $25 billion.
GWPH: 81.75 (-0.02), TMO: 152.19 (-0.97), QDEL: 21.77 (+0.03), ILMN: 168.34 (-0.65)

Akers Biosciences OxiCheck Study Results Positive, Stock Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:21AM CDT
Akers Biosciences Inc. (AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test.
CAH: 79.67 (-0.05), QDEL: 21.77 (+0.03), AKER: 3.58 (-0.10), NUVA: 65.47 (unch)

Alere (ALR) Receives FDA Approval for RSV Molecular Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:16AM CDT
Alere recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test.
QDEL: 21.77 (+0.03), LNTH: 9.52 (-0.07), ALR: 39.13 (-0.18), NUVA: 65.47 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

New Tools Arm Manufacturers in Additive Arena

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Mitsubishi's Q3 Sales: SUVs Up, Mirage Out

You ever notice how the market treats innovation and tradition like they’re these ever-spinning plates in a circus act? Take Mitsubishi Motors North America (MMNA). Their third-quarter report's got me both nodding in approval and scratching my head. Sure, they sold 18,543 vehicles—down 5.6% from the previous year. But don’t write 'em off just yet. The slumping...

Sports Research Joins Costco: Creatine Mix Available

Breaking Into the Big League: Sports Research Hits Costco When a company's product finds its way onto Costco's shelves, you know they're not just playing in the minor leagues anymore. This October, Sports Research® made a bold move into the retail giant's sports nutrition section with their new Creatine + Electrolytes powder. It's not their first rodeo when it comes to...

Cannatrol and Veterans Nonprofit Unite for Healing

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Wisconsin Chefs Transform Pizza with Crave Brothers Cheese

Reimagining Pizza with Wisconsin's Best Cheeses It's not every day you see a pizza challenge that turns a staple of Friday nights into a gastronomic showcase. But that's exactly what's happening in Wisconsin as chefs flex their creativity using Crave Brothers Farmstead Cheese. This is no ordinary cheese-and-pepperoni affair—these culinary pros are cooking up pizzas with...

Quorum Joins LIVE Coalition to Revolutionize Estate Planning

Shaking Up Estate Planning: Quorum Joins LIVE Coalition Here's a fresh shake-up in the world of estate planning. Quorum Federal Credit Union has thrown its hat into the ring as the latest member of the LIVE Coalition, a band of financial, legal, and tech wizards putting estate plans on a modern track. This marks them as the 70th player to dive into this alliance, pushing...

Ultrabench Revolutionizes AI Model Comparison Game

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Gateway Unveils All-In-One Award Travel Platform

Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...

Maternal Health Index: A New Tool With Big Ambitions

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...